Publications by authors named "Ryan Michael Mitchell"
Importance: Although median survival in amyotrophic lateral sclerosis (ALS) is 2 to 4 years, survival ranges from months to decades, creating prognostic uncertainty. Strategies to predict prognosis would benefit clinical management and outcomes assessments of clinical trials.
Objective: To identify biomarkers in plasma and cerebrospinal fluid (CSF) of patients with ALS that can predict prognosis.